Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Autoimmune & immunology R&D Pipeline

Autoimmune, rheumatology, and immunology biologics in clinical development.

Programs 985

Quick answer

Autoimmune & immunology: NovaPharmaNews indexes 985 autoimmune & immunology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Autoimmune, rheumatology, and immunology biologics in clinical development.

Top sponsors

Pipeline programs

Page 7 of 21

  1. TAK-279-3001

    Takeda

    Moderate to Severe Plaque Psoriasis

    phase 3 small molecule active

    1 trial

  2. TAK-279-3002

    Takeda

    Moderate to Severe Plaque Psoriasis

    phase 3 small molecule active

    1 trial

  3. TAK-279-PsA-3001

    Takeda

    Psoriatic Arthritis

    phase 3 small molecule active

    1 trial

  4. TAK-279-PsA-3002

    Takeda

    Active Psoriatic Arthritis Stratified by Prior Biologic Use

    phase 3 small molecule active

    1 trial

  5. TAK-279-PsA-3003

    Takeda

    Psoriatic Arthritis

    phase 3 small molecule active

    1 trial

  6. TAK-279-PsO-3004

    Takeda

    Moderate to Severe Plaque Psoriasis

    phase 3 small molecule active

    1 trial

  7. TD-1473 Dose A

    Theravance Biopharma Ireland Umited

    Ulcerative Colitis (UC)

    phase 3 small molecule terminated

    2 trials

  8. TILD-19-07

    Lacuna Pharma Pty Ltd

    Psoriatic Arthritis

    phase 3 small molecule active

    1 trial

  9. TILD-19-12

    Lacuna Pharma Pty Ltd

    Treatment of pediatric subjects with moderate to severe chronic plaque psoriasis

    phase 3 small molecule active

    1 trial

  10. TILD-19-19

    Lacuna Pharma Pty Ltd

    Psoriatic Arthritis

    phase 3 small molecule active

    1 trial

  11. TILD-24-01

    Lacuna Pharma Pty Ltd

    Moderate to Severe Genital Psoriasis

    phase 3 small molecule active

    1 trial

  12. Tacrolimus

    Takeda

    Ulcerative Colitis

    phase 3 small molecule terminated

    1 trial

  13. Tacrolimus capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Myasthenia Gravis

    phase 3 small molecule completed

    1 trial

  14. Tacrolimus capsule

    Astellas Pharma Inc

    Myasthenia Gravis

    phase 3 small molecule completed

    1 trial

  15. Tacrolimus capsules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lupus Nephritis

    phase 3 small molecule completed

    1 trial

  16. Telitacicept

    Vor Biopharma

    Generalized Myasthenia Gravis

    phase 3 mab active

    1 trial

  17. Telitacicept

    Vor Biopharma

    Systemic Lupus Erythematosus

    phase 3 mab terminated

    2 trials

  18. The STARS trial

    The George Institute

    juvenile idiopathic arthritis

    phase 3 small molecule active

    1 trial

  19. Tocilizumab 162 mg

    Hoffmann-La Roche

    Rheumatoid Arthritis

    phase 3 small molecule completed

    1 trial

  20. Tofacitinib 5 mg BID

    Pfizer

    Psoriatic Arthritis

    phase 3 small molecule completed

    1 trial

  21. Topical roflumilast

    Arcutis Biotherapeutics

    Chronic Plaque Psoriasis

    phase 3 small molecule completed

    1 trial

  22. Treatment of TongBi Capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Knee Osteoarthritis

    phase 3 small molecule active

    1 trial

  23. Upadacitinib

    AbbVie

    Ulcerative Colitis

    phase 3 small molecule active

    1 trial

  24. Upadacitinib

    AbbVie

    Systemic Lupus Erythematosus

    phase 3 small molecule active

    1 trial

  25. Upadacitinib

    AbbVie

    Spondyloarthritis

    phase 3 small molecule completed

    1 trial

  26. Upadacitinib

    AbbVie

    Crohn's Disease

    phase 3 small molecule active

    2 trials

  27. Upadacitinib (ABT-494)

    AbbVie

    Ulcerative Colitis (UC)

    phase 3 small molecule active

    1 trial

  28. Ustekinumab

    The First People's Hospital of Lianyungang

    Crohn Disease

    phase 3 small molecule active

    1 trial

  29. Ustekinumab Dose Based on BSA and Body Weight

    Janssen Cilag International NV

    Colitis, Ulcerative

    phase 3 small molecule completed

    1 trial

  30. VAY736F12301E1

    Novartis Pharmaceuticals

    Systemic Lupus Erythematosus

    phase 3 small molecule active

    1 trial

  31. VIB0551.P3.S1

    Elan Pharma International

    Myasthenia Gravis which is either due to acetylcholine receptor antibodies (AChR) or muscle specific kinase antibodies (MuSK).

    phase 3 small molecule active

    1 trial

  32. VISIPAQUE d’I/mL for Knee OsteoArthritis

    Pari Pharma GmbH

    Knee OsteoArthritis

    phase 3 small molecule active

    1 trial

  33. VX-509

    Vertex Pharmaceuticals (Australia) Pty.

    Rheumatoid Arthritis

    phase 3 small molecule completed

    3 trials

  34. Vedolizumab

    Takeda

    Colitis, Ulcerative

    phase 3 small molecule completed

    5 trials

  35. Vedolizumab

    Takeda

    Ulcerative Colitis

    phase 3 small molecule completed

    9 trials

  36. Vedolizumab 300 mg IV

    Takeda

    Colitis, Ulcerative

    phase 3 small molecule completed

    1 trial

  37. Vedolizumab IV

    Takeda

    Ulcerative Colitis

    phase 3 small molecule active

    4 trials

  38. Vedolizumab IV

    Takeda

    Moderately to Severely Active Ulcerative Colitis

    phase 3 small molecule active

    1 trial

  39. Vedolizumab IV

    Takeda

    Crohn's Disease (CD)

    phase 3 small molecule active

    1 trial

  40. Vedolizumab IV

    Takeda

    Crohn's Disease

    phase 3 small molecule active

    2 trials

  41. Vedolizumab SC

    Takeda

    Ulcerative Colitis

    phase 3 small molecule active

    1 trial

  42. Vedolizumab SC

    Takeda

    Colitis, Ulcerative

    phase 3 small molecule completed

    1 trial

  43. Vedolizumab SC 108 mg

    Takeda

    Crohn's Disease

    phase 3 small molecule completed

    1 trial

  44. VedolizumabSC-3003

    Takeda

    Active Ulcerative Colitis or Crohn’s Disease

    phase 3 small molecule active

    1 trial

  45. VedolizumabSC-3004

    Takeda

    Ulcerative Colitis or Crohn’s Disease

    phase 3 small molecule active

    1 trial

  46. Vitamin D3

    Hospital Authority, Hong Kong

    Lupus Erythematosus, Systemic

    phase 3 small molecule completed

    1 trial

  47. Voclosporin

    Aurinia Pharmaceuticals

    Adolescent Lupus Nephritis

    phase 3 small molecule terminated

    2 trials

  48. Voclosporin

    Aurinia Pharmaceuticals

    Lupus Nephritis

    phase 3 small molecule completed

    3 trials

Frequently asked questions

How many autoimmune & immunology pipeline programs are tracked?

985 programs match this therapeutic area based on indication text, program name, and registry metadata.

Where does pipeline data come from?

ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.